Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001237648-22-000050)

Filing Details

Accession Number:: 0001237648-22-000050
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-27 12:45:04
Reporting Period:: 2022-12-22

Accepted Time:: 2022-12-27 12:45:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1038133	Heska Corp	HSKA	In Vitro & In Vivo Diagnostic Substances (2835)	770192527

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1570492	S. Kevin Wilson	3760 Rocky Mountain Avenue Loveland CO 80538	Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-12-22	2,299	$59.65	154,913	No	4	P	Direct
Common Stock	Acquisiton	2022-12-22	105	$59.64	155,018	No	4	P	Direct
Common Stock	Acquisiton	2022-12-22	796	$59.62	155,814	No	4	P	Direct
Common Stock	Acquisiton	2022-12-22	240	$59.57	156,054	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	162,763	Indirect	by Cuattro, LLC
Common Stock	9,000	Indirect	by Spouse
Common Stock	138,743	Indirect	by Wilson Family Tr.

Footnotes

The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 1, 2022.